RESEARCH TRIANGLE PARK, N.C. & MIAMI--(BUSINESS WIRE)--Theragenex LLC, a life science and technology company, and PPI, a drug delivery company, announce today that they have reached an agreement to collaborate on marketing PPI’s proprietary technology that is aimed at delivering plasma concentrations through transmucosal delivery that mimics being given via injection.
